Pulvinar Neuro LLC
Durham, NC Pulvinar Neuro Part of Electromedical Products International, Inc.
- UEI
- M3LMPQ8UECM6
- CAGE
- 7PMG8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Electromedical Products International, Inc.
Parent
SNG9YYLE8FM5
- Pulvinar Neuro LLC M3LMPQ8UECM6
-
Electromedical Products International, Inc.
Parent
SNG9YYLE8FM5
- SAM.gov registration date
- Physical address
- 201 W Main St #207, Durham, NC 27701, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development and evaluation of a higher power tacs device for the treatment of SUD - project summary - pulvinar neuro… | National Institute on Drug Abuse | $110,000 | |
| Xcsite 300: cloud-enabled closed-loop transcranial current stimulation device for at-home studies - project summary -… | National Institute of Mental Health | $10,913,423 | |
| Xcsite 200: cloud-enabled transcranial current stimulation research solution for multisite studies | National Institute of Mental Health | $839,243 |
About Pulvinar Neuro LLC
Pulvinar Neuro LLC is a corporate entity registered to receive federal grant awards. It specializes in developing devices and technology related to transcranial alternating current stimulation (tACS) for neuroscience research and potential therapeutic applications.
Pulvinar Neuro has received multiple federal grants from the National Institutes of Health, focusing on advancing tACS technology. One award funded the development of a higher-powered tACS device, XCSITE HPTACS, for treating substance use disorders. The project involved modifying existing equipment, preclinical testing, and a pilot feasibility study in patients. Another major grant supports the XCSITE 300 platform, a cloud-enabled closed-loop tACS system that adapts stimulation based on real-time EEG readings. Plans include evaluating the XCSITE 300 for in-clinic and at-home use in treating depression through double-blind clinical trials. Pulvinar Neuro has also received funding for the XCSITE 200, a cloud-based platform enabling multi-site tACS research studies. Through these grants, primarily from NIDA and NIMH, Pulvinar Neuro aims to advance tACS capabilities for targeted neural circuit modulation and develop potential new treatments for neuropsychiatric conditions like substance abuse and depression.
Quick answers
What is Pulvinar Neuro LLC's UEI?
Pulvinar Neuro LLC's Unique Entity ID (UEI) in SAM.gov is M3LMPQ8UECM6.
What is Pulvinar Neuro LLC's CAGE code?
Pulvinar Neuro LLC's CAGE code is 7PMG8.
What is Pulvinar Neuro LLC's primary NAICS code?
Pulvinar Neuro LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Pulvinar Neuro LLC located?
Pulvinar Neuro LLC's physical address in SAM.gov is 201 W Main St #207, Durham, NC 27701, USA.
Is Pulvinar Neuro LLC registered in SAM.gov?
Yes. Pulvinar Neuro LLC's SAM.gov registration is active through November 25, 2026.
Who is Pulvinar Neuro LLC's parent company?
Pulvinar Neuro LLC is part of Electromedical Products International, Inc.
What is Pulvinar Neuro LLC's most recent federal award?
Pulvinar Neuro LLC's most recent federal grant award is Development and evaluation of a higher power tacs device for the treatment of SUD - project summary - pulvinar neuro… (R43DA054848), from National Institute on Drug Abuse, on September 1, 2021.
On GovTribe
See Pulvinar Neuro LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors